6725-45-7

Basic information

• Product Name: ETHYL 3,4-DICHLOROPHENYLACETATE
• Synonyms: ETHYL 3,4-DICHLOROPHENYLACETATE;ethyl 2-(3,4-dichlorophenyl)acetate
• CAS NO: 6725-45-7
• Molecular Formula: C₁₀H₁₀Cl₂O₂
• Molecular Weight: 233.09
• Product Categories: Esters;Phenyls & Phenyl-Het;Phenyls & Phenyl-Het
• Mol File: 6725-45-7.mol
• Article Data: 14

Chemical Properties

• Melting Point: 24-26°C
• Boiling Point: 291 °C at 760 mmHg
• Flash Point: 116.5 °C
• Appearance: /
• Density: 1.276 g/cm³
• Vapor Pressure: 0.002mmHg at 25°C
• Refractive Index: 1.532
• Water Solubility: Insoluble in water.
• CAS DataBase Reference: ETHYL 3,4-DICHLOROPHENYLACETATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 3,4-DICHLOROPHENYLACETATE(6725-45-7)
• EPA Substance Registry System: ETHYL 3,4-DICHLOROPHENYLACETATE(6725-45-7)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 6725-45-7(Hazardous Substances Data)

Usage

General Description

ETHYL 3,4-DICHLOROPHENYLACETATE is a chemical compound with the molecular formula C10H9Cl2O2. It is a colorless, viscous liquid with a slightly sweet odor. ETHYL 3,4-DICHLOROPHENYLACETATE is used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. It is also utilized in the production of fragrances and flavoring agents. The compound is considered to have low toxicity and is primarily used in industrial and research settings with proper safety precautions.

InChI:InChI=1/C10H10Cl2O2/c1-2-14-10(13)6-7-3-4-8(11)9(12)5-7/h3-5H,2,6H2,1H3

Upstream product

• 64-17-5 ethanol 
• 5807-30-7 3,4-dichlorophenyl acetic acid 
• 623-33-6 glycine ethyl ester hydrochloride 
• 151169-75-4 3,4-dichlophenylboronic acid 

Downstream Products

• 28751-26-0 diethyl (3,4-dichlorophenyl)propanedioate 
• 132604-94-5 erythro-2-(3,4-dichlorophenyl)-4-cyano-3-phenylbutanoate d'ethyle 
• 41204-08-4 ethyl α-bromo-3,4-dichlorophenylacetate 
• 35364-79-5 2-(3,4-dichlorophenyl)ethanol 
• 81156-65-2 2-(3,4-dichlorophenyl)ethyl methanesulfonate 
• 119744-95-5 ({[2-(3,4-Dichloro-phenyl)-ethyl]-ethyl-carbamoyl}-methyl)-carbamic acid tert-butyl ester 
• 119745-52-7 [(S)-1-{(R)-1-[({[2-(3,4-Dichloro-phenyl)-ethyl]-ethyl-carbamoyl}-methyl)-carbamoyl]-4-guanidino-butylcarbamoyl}-2-(4-hydroxy-phenyl)-ethyl]-carbamic acid tert-butyl ester 
• 66504-40-3 1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane 
• 66504-44-7 (±)-1-(3,4 dichlorophenyl)-3-azabicyclo[3.1.0]-hexane-2,4-dione 
• 66504-43-6 (1R,2S)-1-(3,4-Dichloro-phenyl)-cyclopropane-1,2-dicarboxylic acid 
• 66504-42-5 (1R,2S)-1-(3,4-Dichloro-phenyl)-cyclopropane-1,2-dicarboxylic acid diethyl ester 
• 116731-95-4 trans-3-(3,4-dichlorophenyl)-4-phenylpiperidin-2-one 
• 116731-95-4 cis-3-(3,4-dichlorophenyl)-4-phenylpiperidin-2-one 
• 129430-62-2 meso-diethyl 2,3-bis(3,4-difluorophenyl)succinate 

Relevant articles and documents

2-(Halogenated Phenyl) acetamides and propanamides as potent TRPV1 antagonists

A series consisting of 117 2-(halogenated phenyl) acetamide and propanamide analogs were investigated as TRPV1 antagonists. The structure–activity analysis targeting their three pharmacophoric regions indicated that halogenated phenyl A-region analogs exhibited a broad functional profile ranging from agonism to antagonism. Among the compounds, antagonists 28 and 92 exhibited potent antagonism toward capsaicin for hTRPV1 with Ki[CAP] = 2.6 and 6.9 nM, respectively. Further, antagonist 92 displayed promising analgesic activity in vivo in both phases of the formalin mouse pain model. A molecular modeling study of 92 indicated that the two fluoro groups in the A-region made hydrophobic interactions with the receptor.

Synthesis & characterization of 2-(substituted-phenyl)acetohydrazide analogs, 1,3,4-oxadiazoles, and 1,2,4-triazine Ring Systems: A novel class of potential analgesic and anti-inflammatory agents

The new series of 2-(substituted-phenyl)acetohydrazides analogs, S-alkylated 5-substituted-1,3,4-oxadiazoles-2-thione derivatives and 5-arylidene-3-substituted-1,2,4-triazines have been synthesized in good yields and characterized by IR, NMR, mass spectral and elemental analyses. All the synthesized compounds 4(a-d), 5(a-d), 7(a-b), and 8(a-f) are evaluated for their in vitro DPPH scavenging, antimicrobial activity, in vivo analgesic, anti-inflammatory activities. The results of the anti-inflammatory activity are supported by molecular docking study with mouse COX-1 (PDB ID: 2CZT) and COX-2 (PDB ID: 3LN1) enzymes to predict their putative interactions. Among all the assays conducted, the compounds 5-(4-bromophenyl)-3-(naphthalen-2-ylmethyl)-1,2,4-triazine (4d) and2-{[5-(diphenylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-N-(pyrazin-2-yl)acetamide (8a) have emerged as the most potent molecules.

Synthesis of α-aryl esters and nitriles: Deaminative coupling of α-aminoesters and α-aminoacetonitriles with arylboronic acids

Transition-metal-free synthesis of α-aryl esters and nitriles using arylboronic acids with α-aminoesters and α-aminoacetonitriles, respectively, as the starting materials has been developed. The reaction represents a rare case of converting C(sp3)-N bonds into C(sp3)-C(sp2) bonds. The reaction conditions are mild, demonstrate good functional-group tolerance, and can be scaled up. Touch base: A transition-metal-free protocol for the synthesis of α-aryl esters and nitriles by deaminative coupling is presented. Strong bases and transition-metal catalysts are not needed. The new synthetic method uses readily available starting materials and demonstrates wide substrate scope.